SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-150235
Filing Date
2013-04-11
Accepted
2013-04-11 07:13:28
Documents
8
Period of Report
2013-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d517367d6k.htm 6-K 13445
2 EXHIBIT 99.1 d517367dex991.htm EX-99.1 374540
3 EXHIBIT 99.2 d517367dex992.htm EX-99.2 92802
4 EXHIBIT 99.3 d517367dex993.htm EX-99.3 27716
5 EXHIBIT 99.4 d517367dex994.htm EX-99.4 10110
6 EXHIBIT 99.5 d517367dex995.htm EX-99.5 10536
7 GRAPHIC g517367g53d04.jpg GRAPHIC 10084
8 GRAPHIC g517367g92f10.jpg GRAPHIC 21879
  Complete submission text file 0001193125-13-150235.txt   574468
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 13754980
SIC: 2834 Pharmaceutical Preparations